{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:27:01Z","timestamp":1787124421709,"version":"build-2736575974"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>This study aimed to investigate whether there were potential drug-drug interactions\n(DDI) of oxcarbazepine in elderly patients with epilepsy during clinical combination therapy and explore the\noptimal initial dosage regimen of oxcarbazepine for elderly patients with epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The effectiveness of oxcarbazepine was mainly determined by measuring the concentrations of its\nactive metabolite, 10-hydroxycarbazepine (MHD). The study developed an MHD population pharmacokinetic\n(PPK) model for elderly patients with epilepsy using nonlinear mixed-effect modelling (NONMEM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>It was found that no combined medications significantly affected the pharmacokinetic processes\nof MHD. Further, we simulated and recommended the optimal initial dosages of oxcarbazepine suitable for\nelderly patients with epilepsy. Dosages of 20, 15, 10, and 5 mg\/kg oxcarbazepine were recommended for\nelderly patients with epilepsy who weighed 40-46 kg, 46-55 kg, 55-76 kg, and 76-100 kg, respectively. At the\nsame time, in accordance with the above administration plan, the probabilities of achieving the target concentrations\nof the oxcarbazepine active metabolite in elderly patients with epilepsy were 99.0-99.4%, 99.0-99.5%,\n98.7-99.6%, and 98.7-99.7%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The study explored potential DDIs and the initial dosage administration of oxcarbazepine in\nelderly patients with epilepsy for the first time. Combined medications did not cause DDI when used by\nelderly patients with epilepsy for treatment, demonstrating the high safety of oxcarbazepine in the treatment of\nelderly patients with epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study recommended the initial dosages of oxcarbazepine for elderly patients with epilepsy.\nTo achieve the same therapeutic concentration ranges, the dosages for elderly patients with epilepsy may need\nto be reduced.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113816128477482260723062011","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:03:21Z","timestamp":1787123001000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploration of Drug-Drug Interactions and Initial Dosage Administration of\nOxcarbazepine in Elderly Patients with Epilepsy"],"prefix":"10.2174","volume":"32","author":[{"given":"Hai-Bo","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China"},{"name":"Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy &amp; School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy &amp; School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Quan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128477482260723062011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/256983\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128477482260723062011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:03:31Z","timestamp":1787123011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/256983\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128477482260723062011","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}